GlassScriptPhysician profile
Joseph J Sposato
NPI 1629144894
$7,444.68
in general payments reported to CMS, 2019-2025
31 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,371 · 2020: $382 · 2021: $833 · 2022: $791 · 2023: $1,327 · 2024: $1,262 · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,068.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,560.31 | 2019-2025 | |
| Amgen INC. | $915.41 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $626.47 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, Extended Holter |
| Janssen Pharmaceuticals, INC | $616.85 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $435.11 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $405.38 | 2019-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $366.31 | 2024-2025 | |
| Pfizer INC. | $309.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $302.59 | 2019-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $280.77 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $205.78 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $195.29 | 2023-2025 | Watchman Flx, Bodyguardian |
| Irhythm Technologies, INC. | $192.63 | 2019-2022 | |
| Abiomed | $186.73 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $185.52 | 2019-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $109.84 | 2023 | Lifesparc |
| Amarin Pharma, INC. | $88.31 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.14 | 2024-2025 | |
| Astellas Pharma US INC | $72.17 | 2019-2021 | |
| Esperion Therapeutics, INC. | $42.52 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $41.61 | 2019-2024 | Evkeeza |
| Braemar Manufacturing, LLC | $38.49 | 2019 | |
| Inspire Medical Systems, INC. | $31.10 | 2025 | Inspire |
| Chiesi USA, INC. | $29.23 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $28.89 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $22.15 | 2025 | Shingrix |
| Baxter Healthcare | $21.57 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Bridgebio Pharma, INC. | $14.39 | 2025 | Attruby |
| Nuwellis, INC. | $11.16 | 2019 | |
| Bardy Diagnostics, INC. | $10.80 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sposato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.